Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

A group has developed therapies that show promise for treating cancer and various other conditions.

Continuing education programs significantly increased rural nurse practitioners' knowledge about PCOS.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Manipulating cell cleanup processes could help treat hair loss.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

A protein called sFRP4 can slow down hair regrowth.

Skin cancer often starts from Lgr5+ progenitor cells.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Melatonin improves cashmere goat hair quality by increasing follicles and reducing skin aging.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.